Nerea Mendez-Barbero Selected Research

Galectin 1 (LGALS1)

1/2022

Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nerea Mendez-Barbero Research Topics

Disease

2	Abdominal Aortic Aneurysm 01/2022 - 07/2019
2	Anaphylaxis (Anaphylactic Shock) 01/2020 - 01/2017
1	Vascular Remodeling 01/2022
1	Inflammation (Inflammations) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Atherosclerosis 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	Aneurysm (Aneurysms) 07/2019

Drug/Important Bio-Agent (IBA)

2	Histamine (Histamine Dihydrochloride)FDA Link 01/2020 - 01/2017
1	LipidsIBA 01/2022
1	Pancreatic Elastase (Elastase)IBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022
1	Galectin 1 (LGALS1)IBA 01/2022
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 01/2022
1	CytokinesIBA 01/2022
1	Platelet Activating FactorIBA 01/2020
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2019
1	Biomarkers (Surrogate Marker)IBA 07/2019
1	CalcineurinIBA 01/2017

Therapy/Procedure

2	Therapeutics 01/2020 - 07/2019